TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive NI Selects15 Cancer Patient Advocates for Director’s Consumer Liaison Group November 23, 1997